These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21507788)

  • 1. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.
    Winterboer TM; Lecci KA; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing use of beta-lactam antibiotics in the critically ill.
    Roberts JA; Lipman J
    Semin Respir Crit Care Med; 2007 Dec; 28(6):579-85. PubMed ID: 18095221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards better ICU antibiotic dosing.
    Lipman J
    Crit Care Resusc; 2000 Dec; 2(4):282-9. PubMed ID: 16597315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.
    Petrosillo N; Drapeau CM; Agrafiotis M; Falagas ME
    Minerva Anestesiol; 2010 Jul; 76(7):509-24. PubMed ID: 20613692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
    Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
    Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principles.
    Soy D; Torres A
    Curr Opin Crit Care; 2006 Oct; 12(5):477-82. PubMed ID: 16943729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success.
    Lodise TP; Butterfield J
    J Hosp Med; 2011 Jan; 6 Suppl 1():S16-23. PubMed ID: 21225946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing use of aminoglycosides in the critically ill.
    Rea RS; Capitano B
    Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious diseases in the critically ill patients.
    Martin SJ; Yost RJ
    J Pharm Pract; 2011 Feb; 24(1):35-43. PubMed ID: 21507873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections.
    Burgess DS
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S99-104. PubMed ID: 15712103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.